BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Truffi M, Mazzucchelli S, Bonizzi A, Sorrentino L, Allevi R, Vanna R, Morasso C, Corsi F. Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy. Int J Mol Sci 2019;20:E1263. [PMID: 30871158 DOI: 10.3390/ijms20061263] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 Luo X, Zhang Q, Chen H, Hou K, Zeng N, Wu Y. Smart Nanoparticles for Breast Cancer Treatment Based on the Tumor Microenvironment. Front Oncol 2022;12:907684. [PMID: 35720010 DOI: 10.3389/fonc.2022.907684] [Reference Citation Analysis]
2 Wei Y, Li K, Zhao W, He Y, Shen H, Yuan J, Pi C, Zhang X, Zeng M, Fu S, Song X, Lee RJ, Zhao L. The Effects of a Novel Curcumin Derivative Loaded Long-Circulating Solid Lipid Nanoparticle on the MHCC-97H Liver Cancer Cells and Pharmacokinetic Behavior. IJN 2022;Volume 17:2225-41. [DOI: 10.2147/ijn.s363237] [Reference Citation Analysis]
3 Shin H, Gil M, Lee I. Association of Elevated Expression Levels of COL4A1 in Stromal Cells with an Immunosuppressive Tumor Microenvironment in Low-Grade Glioma, Pancreatic Adenocarcinoma, Skin Cutaneous Melanoma, and Stomach Adenocarcinoma. JPM 2022;12:534. [DOI: 10.3390/jpm12040534] [Reference Citation Analysis]
4 Saw PE, Chen J, Song E. Targeting CAFs to overcome anticancer therapeutic resistance. Trends Cancer 2022:S2405-8033(22)00055-3. [PMID: 35331673 DOI: 10.1016/j.trecan.2022.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 De P, Aske J, Sulaiman R, Dey N. Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance. Cancers 2022;14:1519. [DOI: 10.3390/cancers14061519] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Guo J, Zeng H, Shi X, Han T, Liu Y, Liu Y, Liu C, Qu D, Chen Y. A CFH peptide-decorated liposomal oxymatrine inactivates cancer-associated fibroblasts of hepatocellular carcinoma through epithelial–mesenchymal transition reversion. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01311-1] [Reference Citation Analysis]
7 Wang H, Zhang R, Li E, Yan R, Ma B, Ma Q. Pan-Cancer Transcriptome and Immune Infiltration Analyses Reveal the Oncogenic Role of Far Upstream Element-Binding Protein 1 (FUBP1). Front Mol Biosci 2022;9:794715. [DOI: 10.3389/fmolb.2022.794715] [Reference Citation Analysis]
8 Duan H, Liu C, Hou Y, Liu Y, Zhang Z, Zhao H, Xin X, Liu W, Zhang X, Chen L, Jin M, Gao Z, Huang W. Sequential Delivery of Quercetin and Paclitaxel for the Fibrotic Tumor Microenvironment Remodeling and Chemotherapy Potentiation via a Dual-Targeting Hybrid Micelle-in-Liposome System. ACS Appl Mater Interfaces 2022. [PMID: 35175043 DOI: 10.1021/acsami.1c23166] [Reference Citation Analysis]
9 Gam DH, Park JH, Kim JH, Beak DH, Kim JW. Effects of Allium sativum Stem Extract on Growth and Migration in Melanoma Cells through Inhibition of VEGF, MMP-2, and MMP-9 Genes Expression. Molecules 2021;27:21. [PMID: 35011253 DOI: 10.3390/molecules27010021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mollah F, Varamini P. Overcoming Therapy Resistance and Relapse in TNBC: Emerging Technologies to Target Breast Cancer-Associated Fibroblasts. Biomedicines 2021;9:1921. [PMID: 34944738 DOI: 10.3390/biomedicines9121921] [Reference Citation Analysis]
11 Yu W, Hu C, Gao H. Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages. Adv Drug Deliv Rev 2021;178:113909. [PMID: 34352354 DOI: 10.1016/j.addr.2021.113909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
12 Mu J, Gao S, Yang J, Wu F, Zhou H. Fundamental and Clinical Applications of Materials Based on Cancer-Associated Fibroblasts in Cancers. Int J Mol Sci 2021;22:11671. [PMID: 34769102 DOI: 10.3390/ijms222111671] [Reference Citation Analysis]
13 Liu F, Li L, Lan M, Zou T, Kong Z, Cai T, Wu XY, Cai Y. Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin-1 Signaling. Mediators Inflamm 2021;2021:7785890. [PMID: 34602858 DOI: 10.1155/2021/7785890] [Reference Citation Analysis]
14 Terceiro LEL, Edechi CA, Ikeogu NM, Nickel BE, Hombach-Klonisch S, Sharif T, Leygue E, Myal Y. The Breast Tumor Microenvironment: A Key Player in Metastatic Spread. Cancers (Basel) 2021;13:4798. [PMID: 34638283 DOI: 10.3390/cancers13194798] [Reference Citation Analysis]
15 An J, Peng C, Tang H, Liu X, Peng F. New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer. Int J Mol Sci 2021;22:9644. [PMID: 34502549 DOI: 10.3390/ijms22179644] [Reference Citation Analysis]
16 Tang L, Mei Y, Shen Y, He S, Xiao Q, Yin Y, Xu Y, Shao J, Wang W, Cai Z. Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy. Int J Nanomedicine 2021;16:5811-29. [PMID: 34471353 DOI: 10.2147/IJN.S321416] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Li W, Little N, Park J, Foster CA, Chen J, Lu J. Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges. Mol Pharm 2021;18:2889-905. [PMID: 34260250 DOI: 10.1021/acs.molpharmaceut.1c00455] [Reference Citation Analysis]
18 Herdiana Y, Wathoni N, Shamsuddin S, Joni IM, Muchtaridi M. Chitosan-Based Nanoparticles of Targeted Drug Delivery System in Breast Cancer Treatment. Polymers (Basel) 2021;13:1717. [PMID: 34074020 DOI: 10.3390/polym13111717] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Zhang Q, Wang W, Shen H, Tao H, Wu Y, Ma L, Yang G, Chang R, Wang J, Zhang H, Wang C, Zhang F, Qi J, Mi C. Low-Intensity Focused Ultrasound-Augmented Multifunctional Nanoparticles for Integrating Ultrasound Imaging and Synergistic Therapy of Metastatic Breast Cancer. Nanoscale Res Lett 2021;16:73. [PMID: 33928450 DOI: 10.1186/s11671-021-03532-z] [Reference Citation Analysis]
20 Gu X, Gao Y, Wang P, Wang L, Peng H, He Y, Liu Y, Feng N. Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis. J Control Release 2021;333:374-90. [PMID: 33798666 DOI: 10.1016/j.jconrel.2021.03.039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
21 Briolay T, Petithomme T, Fouet M, Nguyen-Pham N, Blanquart C, Boisgerault N. Delivery of cancer therapies by synthetic and bio-inspired nanovectors. Mol Cancer 2021;20:55. [PMID: 33761944 DOI: 10.1186/s12943-021-01346-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
22 Yang Z, Zhang L, Zhu H, Zhou K, Wang H, Wang Y, Su R, Guo D, Zhou L, Xu X, Song P, Zheng S, Xie H. Nanoparticle formulation of mycophenolate mofetil achieves enhanced efficacy against hepatocellular carcinoma by targeting tumour-associated fibroblast. J Cell Mol Med 2021;25:3511-23. [PMID: 33713546 DOI: 10.1111/jcmm.16434] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Mokgautsi N, Wen YT, Lawal B, Khedkar H, Sumitra MR, Wu ATH, Huang HS. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential GSK3β/β-Catenin/STAT3/CD44 Suppressor with Anti-Glioblastoma Properties. Int J Mol Sci 2021;22:2464. [PMID: 33671112 DOI: 10.3390/ijms22052464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Keihan Shokooh M, Emami F, Jeong JH, Yook S. Bio-Inspired and Smart Nanoparticles for Triple Negative Breast Cancer Microenvironment. Pharmaceutics 2021;13:287. [PMID: 33671698 DOI: 10.3390/pharmaceutics13020287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sitia L, Bonizzi A, Mazzucchelli S, Negri S, Sottani C, Grignani E, Rizzuto MA, Prosperi D, Sorrentino L, Morasso C, Allevi R, Sevieri M, Silva F, Truffi M, Corsi F. Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax. Cells 2021;10:328. [PMID: 33562504 DOI: 10.3390/cells10020328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Piscatelli JA, Ban J, Lucas AT, Zamboni WC. Complex Factors and Challenges that Affect the Pharmacology, Safety and Efficacy of Nanocarrier Drug Delivery Systems. Pharmaceutics 2021;13:114. [PMID: 33477395 DOI: 10.3390/pharmaceutics13010114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Yang M, Li J, Gu P, Fan X. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment. Bioact Mater 2021;6:1973-87. [PMID: 33426371 DOI: 10.1016/j.bioactmat.2020.12.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
28 Qi L, Song F, Han Y, Zhang Y, Ding Y. Atractyloside targets cancer-associated fibroblasts and inhibits the metastasis of colon cancer. Ann Transl Med 2020;8:1443. [PMID: 33313188 DOI: 10.21037/atm-20-1531] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 Emami F, Pathak S, Nguyen TT, Shrestha P, Maharjan S, Kim JO, Jeong JH, Yook S. Photoimmunotherapy with cetuximab-conjugated gold nanorods reduces drug resistance in triple negative breast cancer spheroids with enhanced infiltration of tumor-associated macrophages. J Control Release 2021;329:645-64. [PMID: 33022330 DOI: 10.1016/j.jconrel.2020.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 van der Spek YM, Kroep JR, Tollenaar RAEM, Mesker WE. Chemotherapy resistance and stromal targets in breast cancer treatment: a review. Mol Biol Rep 2020;47:8169-77. [PMID: 33006013 DOI: 10.1007/s11033-020-05853-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
31 Cavallari C, Camussi G, Brizzi MF. Extracellular Vesicles in the Tumour Microenvironment: Eclectic Supervisors. Int J Mol Sci 2020;21:E6768. [PMID: 32942702 DOI: 10.3390/ijms21186768] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 He X, Yang Y, Li L, Zhang P, Guo H, Liu N, Yang X, Xu F. Engineering extracellular matrix to improve drug delivery for cancer therapy. Drug Discovery Today 2020;25:1727-34. [DOI: 10.1016/j.drudis.2020.06.029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
33 Bromma K, Bannister A, Kowalewski A, Cicon L, Chithrani DB. Elucidating the fate of nanoparticles among key cell components of the tumor microenvironment for promoting cancer nanotechnology. Cancer Nanotechnol 2020;11:8. [PMID: 32849921 DOI: 10.1186/s12645-020-00064-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
34 Han P, Cao P, Hu S, Kong K, Deng Y, Zhao B, Li F. Esophageal Microenvironment: From Precursor Microenvironment to Premetastatic Niche. Cancer Manag Res 2020;12:5857-79. [PMID: 32765088 DOI: 10.2147/CMAR.S258215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
35 Park C, Lee J, Son C, Lee N. A survey of herbal medicines as tumor microenvironment‐modulating agents. Phytotherapy Research 2021;35:78-94. [DOI: 10.1002/ptr.6784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
36 Yang J, Wang C, Shi S, Dong C. Nanotechnologies for enhancing cancer immunotherapy. Nano Res 2020;13:2595-616. [DOI: 10.1007/s12274-020-2904-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
37 Dai S, Lv Y, Xu W, Yang Y, Liu C, Dong X, Zhang H, Prabhakar BS, Maker AV, Seth P, Wang H. Oncolytic adenovirus encoding LIGHT (TNFSF14) inhibits tumor growth via activating anti-tumor immune responses in 4T1 mouse mammary tumor model in immune competent syngeneic mice. Cancer Gene Ther 2020;27:923-33. [PMID: 32307442 DOI: 10.1038/s41417-020-0173-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Yi M, Xu L, Jiao Y, Luo S, Li A, Wu K. The role of cancer-derived microRNAs in cancer immune escape. J Hematol Oncol 2020;13:25. [PMID: 32222150 DOI: 10.1186/s13045-020-00848-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 23.0] [Reference Citation Analysis]
39 Salvioni L, Rizzuto MA, Bertolini JA, Pandolfi L, Colombo M, Prosperi D. Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope. Cancers (Basel) 2019;11:E1855. [PMID: 31769416 DOI: 10.3390/cancers11121855] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 20.3] [Reference Citation Analysis]
40 Guo L, Shi D, Meng D, Shang M, Sun X, Zhou X, Liu X, Zhao Y, Li J. New FH peptide-modified ultrasonic nanobubbles for delivery of doxorubicin to cancer-associated fibroblasts. Nanomedicine 2019;14:2957-71. [DOI: 10.2217/nnm-2019-0302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Zhu Y, Yu F, Tan Y, Hong Y, Meng T, Liu Y, Dai S, Qiu G, Yuan H, Hu F. Reversing activity of cancer associated fibroblast for staged glycolipid micelles against internal breast tumor cells. Theranostics 2019;9:6764-79. [PMID: 31660067 DOI: 10.7150/thno.36334] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
42 Qin L, Gabazza EC. Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges. Int J Mol Sci 2019;20:E4313. [PMID: 31484418 DOI: 10.3390/ijms20174313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]